ES3039979T3 - Use of carbamate compound for preventing, alleviating, or treating tremors or tremor syndrome - Google Patents
Use of carbamate compound for preventing, alleviating, or treating tremors or tremor syndromeInfo
- Publication number
- ES3039979T3 ES3039979T3 ES17880232T ES17880232T ES3039979T3 ES 3039979 T3 ES3039979 T3 ES 3039979T3 ES 17880232 T ES17880232 T ES 17880232T ES 17880232 T ES17880232 T ES 17880232T ES 3039979 T3 ES3039979 T3 ES 3039979T3
- Authority
- ES
- Spain
- Prior art keywords
- tremor
- syndrome
- pharmaceutical composition
- essential
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20160170225 | 2016-12-14 | ||
| PCT/KR2017/014743 WO2018111009A1 (ko) | 2016-12-14 | 2017-12-14 | 진전 또는 진전 증후군의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES3039979T3 true ES3039979T3 (en) | 2025-10-28 |
Family
ID=62558966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES17880232T Active ES3039979T3 (en) | 2016-12-14 | 2017-12-14 | Use of carbamate compound for preventing, alleviating, or treating tremors or tremor syndrome |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11033531B2 (enExample) |
| EP (1) | EP3556364B1 (enExample) |
| JP (1) | JP7086076B2 (enExample) |
| KR (1) | KR102635941B1 (enExample) |
| CN (1) | CN110267657B (enExample) |
| AU (1) | AU2017374459B2 (enExample) |
| CL (1) | CL2019001623A1 (enExample) |
| ES (1) | ES3039979T3 (enExample) |
| IL (1) | IL267191B2 (enExample) |
| MX (1) | MX391363B (enExample) |
| MY (1) | MY198417A (enExample) |
| WO (1) | WO2018111009A1 (enExample) |
| ZA (1) | ZA201903749B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2973111T3 (es) * | 2017-11-14 | 2024-06-18 | Sk Biopharmaceuticals Co Ltd | Uso de un compuesto de carbamato para prevenir o tratar enfermedades asociadas con el aumento de la corriente tardía de sodio |
| IL281559B2 (en) * | 2018-09-21 | 2025-06-01 | Sk Biopharmaceuticals Co Ltd | (r)-1-phenyl-2-tetrazolyl ethyl carbamate derivatives and formulations comprising same for use in preventing, alleviating, or treating acute stress disorder or post-traumatic stress disorder |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS50676B (sr) * | 2001-02-27 | 2010-06-30 | Ortho-Mcneil Pharmaceutical Inc. | Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju poremećaja kretanja |
| WO2005097136A1 (en) * | 2004-03-29 | 2005-10-20 | Merck & Co., Inc. | Biaryl substituted pyrazinones as sodium channel blockers |
| US7598279B2 (en) * | 2005-04-22 | 2009-10-06 | Sk Holdings Co., Ltd. | Neurotherapeutic azole compounds |
| EP2114393B1 (en) * | 2007-03-05 | 2013-04-17 | Indus Biotech Private Limited | Pharmaceutical compositions comprising trigonelline and 4-hydroxyisoleucine and a process thereof |
| AU2009348523B2 (en) * | 2009-06-22 | 2015-02-26 | Sk Biopharmaceuticals Co., Ltd. | Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester |
| US8404461B2 (en) | 2009-10-15 | 2013-03-26 | SK Biopharmaceutical Co. Ltd. | Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester |
| JP6062077B2 (ja) * | 2013-03-12 | 2017-01-18 | バイオ−ファーム ソリューションズ カンパニー リミテッド | 小児てんかん及びてんかん関連症侯群の予防又は治療用フェニルカルバメート化合物｛ｐｈｅｎｙｌｃａｒｂａｍａｔｅｃｏｍｐｏｕｎｄｓｆｏｒｕｓｅｉｎｐｒｅｖｅｎｔｉｎｇｏｒｔｒｅａｔｉｎｇｐｅｄｉａｔｒｉｃｅｐｉｌｅｓｙａｎｄｅｐｉｌｅｓｙ−ｒｅｌａｔｅｄｓｙｎｄｒｏｍｅｓ｝ |
| KR102489052B1 (ko) * | 2016-05-19 | 2023-01-16 | 에스케이바이오팜 주식회사 | 섬유근육통 또는 섬유근육통의 연관된 기능적 증후군을 예방 또는 치료하기 위한 카바메이트 화합물의 용도 |
-
2017
- 2017-12-14 KR KR1020197018409A patent/KR102635941B1/ko active Active
- 2017-12-14 JP JP2019531817A patent/JP7086076B2/ja active Active
- 2017-12-14 EP EP17880232.8A patent/EP3556364B1/en active Active
- 2017-12-14 ES ES17880232T patent/ES3039979T3/es active Active
- 2017-12-14 MY MYPI2019003351A patent/MY198417A/en unknown
- 2017-12-14 MX MX2019006941A patent/MX391363B/es unknown
- 2017-12-14 CN CN201780077642.3A patent/CN110267657B/zh active Active
- 2017-12-14 WO PCT/KR2017/014743 patent/WO2018111009A1/ko not_active Ceased
- 2017-12-14 AU AU2017374459A patent/AU2017374459B2/en active Active
- 2017-12-14 US US16/468,936 patent/US11033531B2/en active Active
-
2019
- 2019-06-10 IL IL267191A patent/IL267191B2/en unknown
- 2019-06-11 ZA ZA2019/03749A patent/ZA201903749B/en unknown
- 2019-06-12 CL CL2019001623A patent/CL2019001623A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR102635941B1 (ko) | 2024-02-13 |
| KR20190087573A (ko) | 2019-07-24 |
| MY198417A (en) | 2023-08-29 |
| RU2019121914A (ru) | 2021-01-15 |
| IL267191B1 (en) | 2023-01-01 |
| CN110267657A (zh) | 2019-09-20 |
| CA3046300A1 (en) | 2018-06-21 |
| MX2019006941A (es) | 2019-09-06 |
| CN110267657B (zh) | 2022-12-13 |
| CL2019001623A1 (es) | 2019-08-23 |
| EP3556364B1 (en) | 2025-08-27 |
| AU2017374459B2 (en) | 2023-04-27 |
| IL267191B2 (en) | 2023-05-01 |
| EP3556364A1 (en) | 2019-10-23 |
| JP2020502137A (ja) | 2020-01-23 |
| BR112019012000A2 (pt) | 2019-10-29 |
| RU2019121914A3 (enExample) | 2021-04-21 |
| ZA201903749B (en) | 2022-01-26 |
| US11033531B2 (en) | 2021-06-15 |
| EP3556364A4 (en) | 2020-06-17 |
| AU2017374459A1 (en) | 2019-07-04 |
| MX391363B (es) | 2025-03-21 |
| WO2018111009A1 (ko) | 2018-06-21 |
| JP7086076B2 (ja) | 2022-06-17 |
| US20190336481A1 (en) | 2019-11-07 |
| IL267191A (enExample) | 2019-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2251242T3 (es) | Medio para tratar y diagnosticar el sindrome de piernas inquietas. | |
| JP2019516707A (ja) | 繊維筋痛又は繊維筋痛の関連する機能的症候群を予防又は治療するためのカルバメート化合物の使用 | |
| JPWO2006132275A1 (ja) | 運動障害の予防および／または治療剤 | |
| JP7578747B2 (ja) | 欠神発作又は欠神発作を示すてんかんの予防、軽減又は治療のためのカルバメート化合物の使用 | |
| CN110267657B (zh) | 氨基甲酸酯化合物用于预防、缓解或治疗震颤或震颤综合征的用途 | |
| ES2315569T3 (es) | Procedimiento de tratamiento de trastornos del movimiento usando derivados de acido barbiturico. | |
| ES2887338T3 (es) | Uso de un compuesto de carbamato para prevenir o tratar la neuralgia del trigémino | |
| CN110290788A (zh) | 氨基甲酸酯化合物用于预防、缓解或治疗双相障碍的用途 | |
| ES2656905T3 (es) | Agente para mejorar la disinergia vesicouretral | |
| ES2286453T3 (es) | Tratamiento de la discinesia. | |
| CN113242735A (zh) | 使用氨基甲酸酯化合物预防、缓解或治疗并发的癫痫发作 | |
| ES2836685T3 (es) | Agente para aliviar la hiperactividad del detrusor con deterioro de la contractilidad | |
| CA3046300C (en) | Use of carbamate compound for preventing, alleviating, or treating tremors or tremor syndrome | |
| ES2975254T3 (es) | Uso de compuestos de carbamato para la prevención, alivio o tratamiento del prurito | |
| RU2776368C2 (ru) | Применение карбаматного соединения для профилактики, облегчения или лечения треморов или синдрома тремора | |
| HK40015061A (en) | Use of carbamate compounds for preventing, alleviating, or treating tremors or tremor syndrome | |
| HK40015061B (en) | Use of carbamate compounds for preventing, alleviating, or treating tremors or tremor syndrome | |
| BR112019012000B1 (pt) | Uso de um composto de carbamato | |
| RU2783733C1 (ru) | Применение соединения карбамата для предотвращения, облегчения или лечения диабетической периферической нейропатии или индуцированной химиотерапией периферической нейропатии | |
| CN106413698A (zh) | 耳鸣患者的治疗用药剂 |